Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Reverse Transcriptase Inhibitors in Aicardi Goutieres Syndrome

Trial Profile

Reverse Transcriptase Inhibitors in Aicardi Goutieres Syndrome

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 11 Oct 2017

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
  • Indications Hepatitis B; HIV infections; Primary biliary cirrhosis
  • Focus Pharmacodynamics
  • Acronyms RTIAGS
  • Most Recent Events

    • 11 Oct 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top